IBEX 35
11.097,20 -21,70 (-0,20%) Euro Stoxx 50
4.933,19 -2,78 (-0,06%) Dólar/Euro
1,0689 -0,0026 (-0,25%) Petróleo Brent
85,76 +0,75 (+0,88%) Oro
2.321,90 -8,90 (-0,38%) Bitcoin EUR
57.300,73 -20,33 (-0,04%)
908 Devices Inc. (MASS)
Después del cierre:
908 Devices Inc.
645 Summer Street
Boston, MA 02210
United States
857 254 1500
https://908devices.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 230
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Kevin J. Knopp Ph.D. | Co-Founder, CEO, President & Director | 761,12k | N/A | 1973 |
| Mr. Joseph H. Griffith IV | CFO & Treasurer | 491,89k | N/A | 1975 |
| Mr. Michael S. Turner Esq., J.D. | Chief Legal & Administrative Officer and Secretary | 470,65k | N/A | 1967 |
| Dr. Christopher David Brown Ph.D. | Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board | 459,7k | N/A | 1975 |
| Mr. Steve Araiza | Co-Founder | N/A | N/A | N/A |
| Mr. Andrew Bartfay | Co-Founder & Director of Hardware Development | N/A | N/A | N/A |
| Mr. Michael Jobin | Co-Founder & Director of Product Development | N/A | N/A | N/A |
| Dr. Scott Miller Ph.D. | Co-Founder & Director of MS Engineering | N/A | N/A | N/A |
| Ms. Barbara Russo | VP of Marketing & Corporate Communications | N/A | N/A | 1963 |
| Mr. Don Osmer | Vice President of Human Resources | N/A | N/A | 1965 |
Descripción
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Gobierno corporativo
El ISS Governance QualityScore de 908 Devices Inc., a día 1 de junio de 2024, es 7. Las puntuaciones base son Auditoría: 5; Tablero: 5; Derechos de los accionistas: 8; Compensación: 7.
